Intragastric balloons market to reach USD 115.3M

Intragastric balloons market is estimated to reach USD 115.3 million by 2033.

Market overview & size
Intragastric balloons are temporary, non-surgical weight-loss devices placed in the stomach to reduce gastric capacity. These devices are used in adults who are overweight or suffer from obesity and have not responded to diet, exercise, or pharmacotherapy. These balloons offer a less invasive alternative to bariatric surgery.

In 2023, the global intragastric balloons market was valued at $32.2 million, according to Allied Market Research data. The market is projected to grow significantly over the next decade, driven by rise in obesity rates, surge in awareness of non-surgical weight-loss options, technological improvements, and developments in healthcare infrastructure in emerging regions.

Prime determinants of growth
Rise in obesity rates, preference for non-surgical options, and increase in awareness and acceptance are the major factors that drive the growth of the intragastric balloons market. However, limited reimbursement policies and safety concerns hinder the market growth. Moreover, technological advancements and untapped markets in developing economies offer remunerative opportunities for the expansion of the global intragastric balloons market.

Segment highlights
The single intragastric balloons segment to maintain its leadership status during the forecast period
By type, the single intragastric balloons segment generated the largest revenue in the intragastric balloons market in 2023. The single intragastric balloons are often preferred over double or triple balloons due to their simplicity and reduced risk of complications. Single balloons require only one insertion procedure, minimizing patient discomfort and procedural time. Additionally, they may offer easier adjustment and removal processes. While double or triple balloons may provide greater volume for weight loss, the complexity of multiple balloons increases the risk of adverse events such as migration or discomfort, making single balloons a preferred choice for many patients and clinicians.

The saline-filled segment to maintain its leadership status during the forecast period
By filling material, the saline-filled segment generated the largest revenue in the intragastric balloons market in 2023, owing to its advantages over gas-filled balloons. Saline-filled balloons offer greater adjustability, providing more precise volume control and customization for individual patient needs. They also pose a lower risk of deflation and migration, enhancing safety and efficacy in weight loss management.

The hospital segment to maintain its leadership status during the forecast period
By end user, the hospital segment generated the largest revenue in the intragastric balloons market in 2023. Hospitals are the primary users of intragastric balloons due to their advanced medical facilities and expertise in minimally invasive procedures. Hospitals offer comprehensive pre-procedural evaluations, insertion, and post-procedural care, ensuring optimal patient outcomes. Additionally, hospitals have the necessary equipment and personnel to manage potential complications effectively, providing patients with a safe and supportive environment for intragastric balloon placement and monitoring.

Regional outlook
North America leads the utilization of intragastric balloons, driven by advanced healthcare infrastructure and a high prevalence of obesity. In contrast, the Asia-Pacific (APAC) region is experiencing rapid growth in intragastric balloon usage due to increase in awareness of obesity-related health risks and rise in healthcare expenditure. As Asia-Pacific countries adopt Western lifestyles and face escalating obesity rates, the demand for weight management interventions such as intragastric balloons is expected to surge. Allied Market Research